首页> 外文OA文献 >The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: A systematic review and meta-analysis
【2h】

The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: A systematic review and meta-analysis

机译:严重抑郁症,双相情感障碍和精神分裂症阻塞性睡眠呼吸暂停的患病率和预测因素:系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AbstractBackground Obstructive sleep apnea (OSA) is a health hazard since it is associated with neurocognitive dysfunction and cardio-metabolic diseases. The prevalence of OSA among people with serious mental illness (SMI) is unclear. Method We searched major electronic databases from inception till 06/2015. Articles were included that reported the prevalence of OSA determined by polysomnography (PSG) or an apnea-hypopnea index (AHI) >5 events/hr, in people with major depressive disorder (MDD), bipolar disorder (BD) or schizophrenia. A random effects meta-analysis calculating the pooled prevalence of OSA and meta-regression of potential moderators were performed. Results Twelve articles were included representing 570,121 participants with SMI (mean age=38.3 years (SD=7.5)), 45.8% male (range=32-80.4) and mean body mass index (BMI) 25.9 (SD=3.7). The prevalence of OSA in SMI in clinical studies was 25.7% (95% CI 13.9 to 42.4%, n=1,535). Higher frequencies of OSA were seen in MDD (36.3%, 19.4 - 57.4%, n=525) than in BD (24.5%, 95% CI 10.6 - 47.1, n=681) and schizophrenia (15.4%, 95% CI 5.3 - 37.1%, n=329). The prevalence of OSA in 568,586 people with SMI from population cohort studies was 10.7% (95% CI 2.4 - 37.0%) and 19.8% (95% CI 2.5 - 70.0%) in 358,853 people with MDD. Increasing age (β=0.063, 95% CI 0.0005 -0.126, p=0.04, N=10) and BMI predicted increased prevalence of OSA (β=0.1642, 95% CI 0.004 - 0.3701, p=0.04, N=9). Conclusion People with SMI (particularly MDD) have a high prevalence of OSA. Screening for and interventions to manage OSA in SMI including those focused on reducing BMI are warranted.
机译:摘要背景阻塞性睡眠呼吸暂停(OSA)是一种健康危害,因为它与神经认知功能障碍和心脏代谢性疾病有关。目前尚不清楚严重精神疾病(SMI)患者中OSA的患病率。方法从开始到2015年6月6日,我们搜索了主要的电子数据库。纳入的文章报道了在严重抑郁症(MDD),双相情感障碍(BD)或精神分裂症患者中通过多导睡眠监测(PSG)或呼吸暂停低通气指数(AHI)> 5事件/小时确定的OSA患病率。进行了随机效应荟萃分析,计算了OSA的合并患病率和潜在主持人的荟萃回归。结果共纳入12篇文章,代表570121名SMI参与者(平均年龄= 38.3岁(SD = 7.5)),45.8%男性(范围= 32-80.4)和平均体重指数(BMI)25.9(SD = 3.7)。在临床研究中,SMI中OSA的患病率为25.7%(95%CI 13.9至42.4%,n = 1,535)。 MDD(36.3%,19.4-57.4%,n = 525)患OSA的频率高于BD(24.5%,95%CI 10.6-47.1,n = 681)和精神分裂症(15.4%,95%CI 5.3- 37.1%,n = 329)。人群队列研究显示,在568,586名SMI患者中,OSA的患病率为358,853名MDD患者,分别为10.7%(95%CI 2.4-37.0%)和19.8%(95%CI 2.5-70.0%)。年龄增加(β= 0.063,95%CI 0.0005 -0.126,p = 0.04,N = 10),BMI预测OSA患病率增加(β= 0.1642,95%CI 0.004-0.3701,p = 0.04,N = 9)。结论SMI(尤其是MDD)患者的OSA患病率很高。必须对SMI中的OSA进行筛查和干预,包括那些旨在降低BMI的干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号